DSM Nutritional Products Closes Pentapharm Deal
DSM said that it is the clear goal to create the global leading supplier of cosmetic active ingredients with Pentapharm’s track-record in positioning and introduction of innovative products.
30/08/07 DSM Nutritional Products Ltd. has announced the legal closing of the acquisition of Pentapharm Holding Ltd., as already announced on July 5. This deal fits well into DSM’s Vision 2010 strategy to focus on accelerating and innovative growth and also allows Pentapharm to sustain and exceed its defined growth targets.
Caspar Stürm, Pentapharm’s CEO for almost 25 years, has handed over the ownership of the company to DSM with the confidence to have secured the future of the Pentapharm tradition. Dr. Ute Schick, Director of DSM Nutritional Products New Business Development – Personal Care will be the successor of Mr. Stürm.
DSM said that it is the clear goal to create the global leading supplier of cosmetic active ingredients by combining DSM’s excellent capabilities in terms of claim substantiation, test design and regulatory environment, with Pentapharm’s track-record in positioning and introduction of innovative products.
DSM’s strategy aims at creating value with this acquisition by inter-linking the two company’s complementary strengths. Therefore the integration will be based on best knowledge in both companies to provide the most beneficial outcome.
Since the joint integration planning has just started, no immediate changes are to be expected for any of the internal or external stakeholders. All Pentapharm contact persons for orders, supply and other requests will remain unchanged for the time being and be at customers' disposal with the same high level of service standard they are used to. Some visions regarding the future of the combined entities have already been defined.
With the new and potent owner DSM in the back, Pentapharm is looking forward to an outstanding and long-lasting relationship with existing and new partners.
